Danske Bank’s BioVie BIVI Stock Holding History

Danske Bank’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1158
2025 Q4	$1	Hold	1	–	–	﹤0.01%	1547
2025 Q3	$2	Buy	+1	New	+$4	﹤0.01%	1463

Other funds holding BIVI

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Danske Bank's BIVI Position: Q1 2026 in Review

Danske Bank held its BioVie (BIVI) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Danske Bank first reported a position in BIVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $2 in Q3 2025. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

Danske Bank held 1 share of BioVie worth $1 as of Q1 2026.
Danske Bank left its BioVie share count unchanged in Q1 2026.
BioVie made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1158 holding.
Danske Bank first reported a position in BioVie in Q3 2025 and has held it in 3 quarters since.
Danske Bank's BioVie position peaked at $2 in Q3 2025.
33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.